May 2024
1. XU N, Wang X, Dai T, Liu N, et al
   Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
   Clin Rheumatol. 2024;43:1683-1692.
   

   >> Share

   
   
2. LU L, Dai T, Zhao Y, Qu H, et al
   The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
   Clin Rheumatol. 2024;43:1675-1682.
   

   >> Share

   
   
3. CAI B, Guo Z, Yan Q, Li H, et al
   Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
   Clin Rheumatol. 2024;43:1665-1674.
   

   >> Share

   
   
4. AN Q, Ma R, Yuan D, Huang J, et al
   Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
   Clin Rheumatol. 2024;43:1491-1501.
   

   >> Share

   
   
5. LI H, Jin Y, He J
   Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
   Clin Rheumatol. 2024;43:1777.
   

   >> Share

   
   April 2024
6. SHEAHAN A, Anjohrin S, Suruki R, Stark JL, et al
   Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
   Clin Rheumatol. 2024 Apr 25. doi: 10.1007/s10067-024-06945.
   

   >> Share

   
   
7. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
   Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
   Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
   

   >> Share

   
   
8. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
   Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
   Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
   

   >> Share

   
   
9. ZHOU J, Gan Y, Fan X, Qi H, et al
   Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey.
   Clin Rheumatol. 2024 Apr 10. doi: 10.1007/s10067-024-06959.
   

   >> Share

   
   
10. YU T, Qian S, Li M
    Letter to the Editor: "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis".
    Clin Rheumatol. 2024 Apr 6. doi: 10.1007/s10067-024-06924.
    

    >> Share

    
    
11. OLIVEIRA D, Ferreira RM, Gomes CM, Vaz C, et al
    Geiser Sign in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2024 Apr 4. doi: 10.1007/s10067-024-06952.
    

    >> Share

    
    
12. XIE Y, Zhao H
    Real respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1353.
    

    >> Share

    
    
13. DAI W, He H
    Commentary on the respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1419-1420.
    

    >> Share

    
    
14. LIU X, Wang H, Wang X, Jiang X, et al
    Identification and verification of inflammatory biomarkers for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1335-1352.
    

    >> Share

    
    March 2024
15. BIRD A, Oakden-Rayner L, Smith LA, Zeng M, et al
    Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
    Clin Rheumatol. 2024 Mar 27. doi: 10.1007/s10067-024-06946.
    

    >> Share

    
    
16. GUPTA N, Kanwar N, Arora A, Khatri K, et al
    The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
    Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
    

    >> Share

    
    
17. LU F, Chen Q, Qi X, Cong M, et al
    Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters.
    Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
    

    >> Share

    
    
18. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
    

    >> Share

    
    
19. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
    Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
    Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
    

    >> Share

    
    
20. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
    Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
    

    >> Share

    
    
21. PAN J, Wu T, Ma JD, Jia PW, et al
    Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Mar 4. doi: 10.1007/s10067-024-06918.
    

    >> Share

    
    
22. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    

    >> Share

    
    
23. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    

    >> Share

    
    
24. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    

    >> Share

    
    
25. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    

    >> Share

    
    
26. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    

    >> Share

    
    February 2024
27. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    

    >> Share

    
    
28. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    

    >> Share

    
    
29. FERNANDEZ-AVILA DG, Patino-Hernandez D, Moreno-Luna S, Brance L, et al
    Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 14. doi: 10.1007/s10067-024-06868.
    

    >> Share

    
    
30. LICHTIGER A, Fadaei G, Tagoe CE
    Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
    Clin Rheumatol. 2024 Feb 10. doi: 10.1007/s10067-024-06888.
    

    >> Share

    
    
31. NOMAIR AM, Abdelati A, Dwedar FI, Elnemr R, et al
    The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Feb 5. doi: 10.1007/s10067-024-06892.
    

    >> Share

    
    
32. ZHANG L, Tan M, Mao J, Zhang J, et al
    Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
    

    >> Share

    
    
33. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
    Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
    Clin Rheumatol. 2024;43:733-741.
    

    >> Share

    
    
34. ZHAO R, Dong C, Gu Z, Ding X, et al
    Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:717-724.
    

    >> Share

    
    
35. ZHOU X, Li H, Wang N, Jin Y, et al
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:707-715.
    

    >> Share

    
    
36. SHEN Y, Yu X, Wang Q, Yao X, et al
    Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
    Clin Rheumatol. 2024;43:603-619.
    

    >> Share

    
    January 2024
37. O'BRIEN J, Park SH, Blachley T, Marchese M, et al
    Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
    Clin Rheumatol. 2024 Jan 25. doi: 10.1007/s10067-024-06869.
    

    >> Share

    
    
38. QIAO L, Lv S, Meng K, Yang J, et al
    Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Clin Rheumatol. 2024 Jan 10. doi: 10.1007/s10067-023-06837.
    

    >> Share

    
    
39. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Jan 6. doi: 10.1007/s10067-023-06862.
    

    >> Share

    
    
40. SHIZUKU T, Hagino N
    Hypoglossal nerve palsy due to basilar impression in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jan 3. doi: 10.1007/s10067-023-06863.
    

    >> Share

    
    
41. YIN S, Luo F, Xie J, Zeng Y, et al
    Identification of discriminatory factors and construction of nomograms for differentiating AOSD and sepsis.
    Clin Rheumatol. 2024;43:569-578.
    

    >> Share

    
    
42. RUAN Y, Bi H, Luo X, Pang A, et al
    Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjogren syndrome with thrombocytopenia.
    Clin Rheumatol. 2024;43:307-314.
    

    >> Share

    
    
43. SAMI F, Sami SA, Manadan AM, Arora S, et al
    Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
    Clin Rheumatol. 2024;43:59-65.
    

    >> Share

    
    
44. FARES J, Summer R, Loizidis G
    Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
    Clin Rheumatol. 2024;43:325-338.
    

    >> Share

    
    
45. CHEN L, Chi H, Teng J, Meng J, et al
    Neutralizing anti-IFN-gamma IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
    Clin Rheumatol. 2024;43:189-198.
    

    >> Share

    
    
46. ZHAO P, Peng C, Chang X, Cheng W, et al
    Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:297-306.
    

    >> Share

    
    
47. KIADALIRI A, Dell'Isola A, Englund M
    Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Clin Rheumatol. 2024;43:81-85.
    

    >> Share

    
    
48. CAI D, Zheng Z, Hu J, Fu Y, et al
    Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
    Clin Rheumatol. 2024;43:533-541.
    

    >> Share

    
    December 2023
49. SLOUMA M, Lahmar W, Mohamed G, Dhrif O, et al
    Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2023 Dec 30. doi: 10.1007/s10067-023-06847.
    

    >> Share

    
    
50. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
    Clin Rheumatol. 2023 Dec 28. doi: 10.1007/s10067-023-06850.
    

    >> Share

    
    
51. OZUDOGRU CELIK T
    Letter to the Editor on "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06823.
    

    >> Share

    
    
52. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    Rebuttal Letter to "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06856.
    

    >> Share

    
    
53. D'ALESSANDRO F, Cazzato M, Laurino E, Morganti R, et al
    ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study
    Clin Rheumatol. 2023 Dec 23. doi: 10.1007/s10067-023-06836.
    

    >> Share

    
    
54. LIU H, Zhang Y, Cao J, Li J, et al
    Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.
    Clin Rheumatol. 2023 Dec 14. doi: 10.1007/s10067-023-06840.
    

    >> Share

    
    
55. MO H, Su ZH, Zheng ZY, Gao L, et al
    Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection.
    Clin Rheumatol. 2023 Dec 5. doi: 10.1007/s10067-023-06830.
    

    >> Share

    
    
56. KARAMALI N, Mahmoudi Z, Roghani SA, Assar S, et al
    Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
    Clin Rheumatol. 2023 Dec 4. doi: 10.1007/s10067-023-06808.
    

    >> Share

    
    
57. HE J, Xu C, Zhu Y, Xu M, et al
    Clinical significance of the expression levels of serum transforming growth factor-beta and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
    Clin Rheumatol. 2023;42:3283-3288.
    

    >> Share

    
    
58. SCHMIDT NS, Fana V, Danielsen MA, Lindegaard HM, et al
    The impact of an ultrasound atlas for scoring salivary glands in primary Sjogren's syndrome: a pilot study.
    Clin Rheumatol. 2023;42:3275-3281.
    

    >> Share

    
    
59. YIN H, Yang S, Lu L
    Adie's tonic pupil in primary Sjogren syndrome.
    Clin Rheumatol. 2023;42:3419-3420.
    

    >> Share

    
    November 2023
60. SHAMSI A, Roghani SA, Soufivand P, Pournazari M, et al
    CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 25. doi: 10.1007/s10067-023-06826.
    

    >> Share

    
    
61. PALMOWSKI A, Strehl C, Pfeiffenberger M, Haupl T, et al
    Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 17. doi: 10.1007/s10067-023-06814.
    

    >> Share

    
    
62. RONG JC, Chen XD, Jin NK, Hong J, et al
    Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
    Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06804.
    

    >> Share

    
    
63. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
    Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
    Clin Rheumatol. 2023;42:3033-3041.
    

    >> Share

    
    
64. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
    Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
    Clin Rheumatol. 2023;42:3143-3152.
    

    >> Share

    
    
65. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
    Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
    Clin Rheumatol. 2023;42:3021-3031.
    

    >> Share

    
    
66. WISE L, Zell M
    Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
    Clin Rheumatol. 2023;42:3159-3166.
    

    >> Share

    
    October 2023
67. ADELOWO O, Omokhowa A, Ochiagha O, Uhunmwangho CU, et al
    Comorbidities in Nigerian patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 23. doi: 10.1007/s10067-023-06797.
    

    >> Share

    
    
68. VALLEZ-VALERO L, Gaso-Gago I, Marcos-Fendian A, Garrido-Alejos G, et al
    Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06787.
    

    >> Share

    
    
69. LI WJ, Wang XL, Chu YR, Wang JX, et al
    Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06784.
    

    >> Share

    
    
70. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients.
    Clin Rheumatol. 2023 Oct 9. doi: 10.1007/s10067-023-06780.
    

    >> Share

    
    
71. PAN S, Xiao X, Li T, Wu S, et al
    Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 4. doi: 10.1007/s10067-023-06772.
    

    >> Share

    
    
72. TESCH F, Ehm F, Vivirito A, Wende D, et al
    Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
    Clin Rheumatol. 2023;42:2905-2914.
    

    >> Share

    
    
73. ZIMBA O, Gasparyan AY
    Cardiovascular issues in rheumatic diseases.
    Clin Rheumatol. 2023;42:2535-2539.
    

    >> Share

    
    
74. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Clin Rheumatol. 2023;42:2677-2690.
    

    >> Share

    
    September 2023
75. WEINSTEIN CLJ, Meehan AG, Lin J, Briscoe SD, et al
    Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Clin Rheumatol. 2023 Sep 26. doi: 10.1007/s10067-023-06760.
    

    >> Share

    
    
76. LIU H, Li Q, Long K, Xia O, et al
    Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
    Clin Rheumatol. 2023 Sep 23. doi: 10.1007/s10067-023-06773.
    

    >> Share

    
    
77. NAKAYAMA M, Furuya T, Inoue E, Tanaka E, et al
    Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
    Clin Rheumatol. 2023 Sep 21. doi: 10.1007/s10067-023-06779.
    

    >> Share

    
    
78. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
    Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 14. doi: 10.1007/s10067-023-06768.
    

    >> Share

    
    
79. CHEN YW, Chen HH, Huang WN, Chen JP, et al
    Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 2. doi: 10.1007/s10067-023-06735.
    

    >> Share

    
    
80. PASOTO SG, Borba EF, Formiga FFC, do Nascimento Pedrosa T, et al
    Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjogren syndrome.
    Clin Rheumatol. 2023;42:2419-2425.
    

    >> Share

    
    
81. ONO R, Iwahana T, Toriumi S, Aoki K, et al
    Fulminant myocarditis with adult-onset Still's disease: case-based review.
    Clin Rheumatol. 2023;42:2507-2514.
    

    >> Share

    
    
82. BARRIO-NOGAL L, Novella-Navarro M, Heras CB, Sala-Icardo L, et al
    Ultrasonography in the diagnosis of suspected primary Sjogren's syndrome and concordance with salivary gland biopsy: a Spanish single-center study.
    Clin Rheumatol. 2023;42:2409-2417.
    

    >> Share

    
    August 2023
83. GONG X, Tang Y, Yu SS, Shi W, et al
    Elevated serum leptin may be associated with disease activity and secondary osteoporosis in Chinese patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Aug 30. doi: 10.1007/s10067-023-06725.
    

    >> Share

    
    
84. PAPAMICHAIL GV, Georgiadis AN, Tellis CC, Rapti I, et al
    Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study.
    Clin Rheumatol. 2023 Aug 29. doi: 10.1007/s10067-023-06744.
    

    >> Share

    
    
85. GRAVAND A, Alesaeidi S, Khoshbakht S, Saghaei M, et al
    Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity.
    Clin Rheumatol. 2023 Aug 19. doi: 10.1007/s10067-023-06736.
    

    >> Share

    
    
86. CHEN F, Lang Y, Geng S, Wang X, et al
    Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.
    Clin Rheumatol. 2023 Aug 9. doi: 10.1007/s10067-023-06727.
    

    >> Share

    
    
87. NAGAHATA K, Hagino N
    Unusual pleural effusion in a patient with rheumatoid arthritis: chylothorax.
    Clin Rheumatol. 2023 Aug 4. doi: 10.1007/s10067-023-06730.
    

    >> Share

    
    
88. HUANG Y, Agarwal SK, Chatterjee S, Chen H, et al
    Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study.
    Clin Rheumatol. 2023 Aug 4. doi: 10.1007/s10067-023-06709.
    

    >> Share

    
    
89. BERNAL-BELLO D, Rodriguez-Rodriguez J, Duarte-Millan MA, Frutos-Perez B, et al
    Anti-synthetase syndrome and the risk of progressive pulmonary fibrosis: weighting of concomitant anti-Ro/SSA antibodies.
    Clin Rheumatol. 2023;42:2249-2250.
    

    >> Share

    
    July 2023
90. GONZALEZ DA, Bianchi ML, Armada M, Escalante AC, et al
    Hyposalivation and periodontal disease as oral non-articular characteristics in rheumatoid arthritis.
    Clin Rheumatol. 2023 Jul 28. doi: 10.1007/s10067-023-06718.
    

    >> Share

    
    
91. IYER P, Gao Y, Jalal D, Girotra S, et al
    Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
    Clin Rheumatol. 2023 Jul 27. doi: 10.1007/s10067-023-06714.
    

    >> Share

    
    
92. WANG Y, Xie H, Huang X, Chen K, et al
    Retrospective analysis and preliminary laboratory validation of treatment efficacy and blood lipid levels in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Jul 24. doi: 10.1007/s10067-023-06683.
    

    >> Share

    
    
93. PASHA U, Hanif K, Nisar H, Abid R, et al
    A novel missense compound heterozygous variant in TLR1 gene is associated with susceptibility to rheumatoid arthritis - structural perspective and functional annotations.
    Clin Rheumatol. 2023 Jul 21. doi: 10.1007/s10067-023-06702.
    

    >> Share

    
    
94. KAPLAN H, Cengiz G, Sas S, Eldemir YO, et al
    Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Clin Rheumatol. 2023 Jul 20. doi: 10.1007/s10067-023-06703.
    

    >> Share

    
    
95. ANYFANTI P, Dimitriadou A, Dara A, Angeloudi E, et al
    Circulating levels of galectin-3 and coronary microvascular perfusion in rheumatoid arthritis patients with suppressed inflammation.
    Clin Rheumatol. 2023 Jul 7. doi: 10.1007/s10067-023-06685.
    

    >> Share

    
    
96. CHEN F, Lang Y, Geng S, Wang X, et al
    The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis.
    Clin Rheumatol. 2023 Jul 7. doi: 10.1007/s10067-023-06659.
    

    >> Share

    
    
97. FAREEZ F, Moodley J, Popovic S, Lu JQ, et al
    Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration.
    Clin Rheumatol. 2023;42:1753-1765.
    

    >> Share

    
    
98. METSIOS GS, Fenton SAM, Tzika K, Moe RH, et al
    Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey.
    Clin Rheumatol. 2023;42:1897-1902.
    

    >> Share

    
    June 2023
99. ALTEN R, Tony HP, Bannert B, Nusslein H, et al
    Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus.
    Clin Rheumatol. 2023 Jun 14. doi: 10.1007/s10067-023-06649.
    

    >> Share

    
    
100. SHI G, Liao X, Lin Z, Liu W, et al
     Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the Global Burden of Disease Study 2019.
     Clin Rheumatol. 2023 Jun 9. doi: 10.1007/s10067-023-06628.
     

     >> Share

     
     
101. CONLEY B, Bunzli S, Bullen J, O'Brien P, et al
     What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines.
     Clin Rheumatol. 2023 Jun 9. doi: 10.1007/s10067-023-06654.
     

     >> Share

     
     
102. MACHAJ F, Rosik J, Szostak B, Malinowski D, et al
     The association between CYB5A gene rs1790834 polymorphism and clinical improvement after 6 months of leflunomide treatment in women with rheumatoid arthritis.
     Clin Rheumatol. 2023 Jun 8. doi: 10.1007/s10067-023-06653.
     

     >> Share

     
     
103. ZHANG Y, Luo Q, Lu K, You M, et al
     Subclinical atherosclerosis in primary Sjogren's syndrome: comparable risk with diabetes mellitus.
     Clin Rheumatol. 2023;42:1607-1614.
     

     >> Share

     
     
104. MELIS MR, El Aoufy K, Bambi S, Bruni C, et al
     Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review.
     Clin Rheumatol. 2023;42:1521-1535.
     

     >> Share

     
     
105. WANG H, Geng G, Zhang D, Han F, et al
     Analysis of microRNA-199a-3p expression in CD4(+) T cells of systemic lupus erythematosus.
     Clin Rheumatol. 2023;42:1683-1694.
     

     >> Share

     
     
106. DUAN M, Shen M, Zhou Y, He Y, et al
     AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
     Clin Rheumatol. 2023;42:1635-1643.
     

     >> Share

     
     May 2023
107. MIYAKE H, Sada RM, Akebo H, Tsugihashi Y, et al
     Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study.
     Clin Rheumatol. 2023 May 27. doi: 10.1007/s10067-023-06646.
     

     >> Share

     
     
108. TAKEDA R, Matsumoto T, Omata Y, Inui H, et al
     Changes in knee joint destruction patterns among patients with rheumatoid arthritis undergoing total knee arthroplasty in recent decades.
     Clin Rheumatol. 2023 May 24. doi: 10.1007/s10067-023-06620.
     

     >> Share

     
     
109. SOBUE Y, Suzuki M, Ohashi Y, Koshima H, et al
     Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients.
     Clin Rheumatol. 2023 May 22. doi: 10.1007/s10067-023-06639.
     

     >> Share

     
     
110. MATTESON EL, Aringer M, Burmester GR, Mueller H, et al
     Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
     Clin Rheumatol. 2023 May 20. doi: 10.1007/s10067-023-06623.
     

     >> Share

     
     
111. LV Y, Zhang J, Li C, Wang L, et al
     Network pharmacological analysis to reveal the mechanism governing the effect of Qin Xi Tong on osteoarthritis and rheumatoid arthritis.
     Clin Rheumatol. 2023 May 10. doi: 10.1007/s10067-023-06625.
     

     >> Share

     
     
112. CHEN C, Yang Z
     Hypertension, hyperlipidaemia and anti-Ro52 antibody need to be taken into account: comments on clinical features and high‑risk indicators of central nervous system involvement in primary Sjogren's syndrome.
     Clin Rheumatol. 2023;42:1497-1498.
     

     >> Share

     
     
113. PENA E, Dos Santos LP, do Espirito Santo RC, Guaresi S, et al
     Systemic lupus erythematosus: a systematic review with meta-analysis on muscle strength, muscle mass, and physical function.
     Clin Rheumatol. 2023;42:1237-1248.
     

     >> Share

     
     
114. LI H, Zhou Y, Wang P, Wang Y, et al
     Alterations of CD8(+) T cells in the blood and salivary glands of patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2023;42:1327-1338.
     

     >> Share

     
     
115. WANG F, Zhufeng Y, Chen Z, Xu J, et al
     The composition and function profile of the gut microbiota of patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2023;42:1315-1326.
     

     >> Share

     
     April 2023
116. STROUSE J, Sabih L, Bandoli G, Baer R, et al
     Racial/ethnic disparities in the risk of preterm birth among women with systemic lupus erythematosus or rheumatoid arthritis.
     Clin Rheumatol. 2023 Apr 26. doi: 10.1007/s10067-023-06606.
     

     >> Share

     
     
117. LOPEZ-OLIVO MA, Michaud K, Schumacher R, Minnix J, et al
     Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis.
     Clin Rheumatol. 2023 Apr 24. doi: 10.1007/s10067-023-06593.
     

     >> Share

     
     
118. SEBBA A, Bingham CO, Bykerk VP, Fiore S, et al
     Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry.
     Clin Rheumatol. 2023 Apr 15. doi: 10.1007/s10067-023-06588.
     

     >> Share

     
     
119. DAGHOR-ABBACI K, Hamadouche NA
     Response to letter to the editor: proposal of a new diagnostic algorithm for adult onset Still's disease.
     Clin Rheumatol. 2023;42:1221-1222.
     

     >> Share

     
     
120. BAICUS C
     Diagnostic algorithm of adult-onset Still's disease-unmet need and problems with methodology.
     Clin Rheumatol. 2023;42:1219-1220.
     

     >> Share

     
     
121. DAGHOR-ABBACI K, Ait Hamadouche N, Makhloufi CD, Mechid F, et al
     Proposal of a new diagnostic algorithm for adult-onset Still's disease.
     Clin Rheumatol. 2023;42:1125-1135.
     

     >> Share

     
     
122. ZAMORA-ABRAHAN GT, Salido EO, Lichauco JJT, Gutierrez-Rubio AKM, et al
     Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective.
     Clin Rheumatol. 2023;42:1171-1175.
     

     >> Share

     
     
123. MARTIN-NARES E, Hernandez-Molina G, Lima G, Hernandez-Ramirez DF, et al
     Tear levels of IL-7, IL-1alpha, and IL-1beta may differentiate between IgG4-related disease and Sjogren's syndrome.
     Clin Rheumatol. 2023;42:1101-1105.
     

     >> Share

     
     
124. WANG Q, Dai SM
     An interaction between the inflammatory condition and the hypercoagulable condition occurs in primary Sjogren syndrome.
     Clin Rheumatol. 2023;42:1107-1112.
     

     >> Share

     
     
125. KAMBHATLA S, Vipparthy S, Manadan AM
     Rheumatic diseases associated with alveolar hemorrhage: analysis of the national inpatient sample.
     Clin Rheumatol. 2023;42:1177-1183.
     

     >> Share

     
     
126. MOK CC, Ho LY, Tse SM, Chan KL, et al
     Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
     Clin Rheumatol. 2023;42:1019-1026.
     

     >> Share

     
     March 2023
127. NOGUCHI A, Kurita T, Matsuzawa K
     Clinical features of atlantoaxial involvement in patients with rheumatoid arthritis using (18)F-fluorodeoxyglucose-positron emission tomography with computed tomography.
     Clin Rheumatol. 2023 Mar 31. doi: 10.1007/s10067-023-06586.
     

     >> Share

     
     
128. GERGANOV G, Georgiev T, Dimova M, Shivacheva T, et al
     Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review.
     Clin Rheumatol. 2023 Mar 30. doi: 10.1007/s10067-023-06587.
     

     >> Share

     
     
129. VINICKI JP, Zamora JLV, Salinas RG, Alarcon GS, et al
     How are rheumatologists from Argentina managing patients with arthralgias suspicious for progressing to rheumatoid arthritis?
     Clin Rheumatol. 2023 Mar 28. doi: 10.1007/s10067-023-06581.
     

     >> Share

     
     
130. HOUGE IS, Hoff M, Videm V
     The association between rheumatoid arthritis and reduced estimated cardiorespiratory fitness is mediated by physical symptoms and negative emotions: a cross-sectional study.
     Clin Rheumatol. 2023 Mar 24. doi: 10.1007/s10067-023-06584.
     

     >> Share

     
     
131. CHEN Y, Yuan J, Cai Z, Ma Y, et al
     Efficacy of tumor necrosis factor inhibitor combined with intra-articular injection of triamcinolone acetonide in the treatment of refractory rheumatoid arthritis synovitis: a retrospective study.
     Clin Rheumatol. 2023 Mar 2. doi: 10.1007/s10067-023-06530.
     

     >> Share

     
     
132. EVANGELATOS G, Fragoulis GE
     JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know.
     Clin Rheumatol. 2023;42:959-962.
     

     >> Share

     
     
133. OZTURK O, Feyzioglu O, Saritas F
     Pre-sarcopenia is associated with health-related quality of life in patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2023;42:783-791.
     

     >> Share

     
     
134. MENG X, Xu HJ, Li RL, Zhao LD, et al
     Vocal cord lesions in representative autoimmune diseases.
     Clin Rheumatol. 2023;42:929-939.
     

     >> Share

     
     
135. CHEVALLARD M, Adinolfi A, Belloli L, Casu C, et al
     Active vaccination campaign to increase seasonal influenza vaccination coverage: a monocenter experience in a cohort of Italian patients with systemic autoimmune diseases.
     Clin Rheumatol. 2023;42:923-928.
     

     >> Share

     
     February 2023
136. KHABBAZI A, Gadakchi L, Moslemi M, Khalaji A, et al
     Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study.
     Clin Rheumatol. 2023 Feb 17. doi: 10.1007/s10067-023-06548.
     

     >> Share

     
     
137. ABUELAZM M, Ghanem A, Mahmoud A, Brakat AM, et al
     The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis.
     Clin Rheumatol. 2023 Feb 16. doi: 10.1007/s10067-023-06519.
     

     >> Share

     
     
138. ROGHANI SA, Lotfi R, Soleymani B, Samimi Z, et al
     Investigating the correlation of the NF-kappaB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients.
     Clin Rheumatol. 2023 Feb 4. doi: 10.1007/s10067-023-06521.
     

     >> Share

     
     
139. JIN L, Dai M, Li C, Wang J, et al
     Risk factors for primary Sjogren's Syndrome: a systematic review and meta-analysis.
     Clin Rheumatol. 2023;42:327-338.
     

     >> Share

     
     
140. COX JG, de Groot M, Cole JH, Williams SCR, et al
     A meta-analysis of structural MRI studies of the brain in systemic lupus erythematosus (SLE).
     Clin Rheumatol. 2023;42:319-326.
     

     >> Share

     
     
141. TIENDREBEOGO JWS, Kabore F, Sougue C, Sankara V, et al
     Epidemiology of rheumatic diseases: a cohort of 23,550 patients in rheumatology clinics in Burkina Faso.
     Clin Rheumatol. 2023;42:371-376.
     

     >> Share

     
     
142. FAN W, Par-Young J, Li K, Zhang Y, et al
     Clinical features and high-risk indicators of central nervous system involvement in primary Sjogren's syndrome.
     Clin Rheumatol. 2023;42:443-451.
     

     >> Share

     
     
143. ZHANG Y, Qiao L, Zhang L, Li Q, et al
     Renal tubular acidosis and associated factors in patients with primary Sjogren's syndrome: a registry-based study.
     Clin Rheumatol. 2023;42:431-441.
     

     >> Share

     
     
144. MISRA DP, Pande G, Agarwal V
     Cardiovascular risks associated with Janus kinase inhibitors: peering outside the black box.
     Clin Rheumatol. 2023;42:621-632.
     

     >> Share

     
     January 2023
145. KAKEHASI AM, Radominski SC, Baravalle MD, Palazuelos FCI, et al
     Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.
     Clin Rheumatol. 2023 Jan 30:1-10. doi: 10.1007/s10067-023-06513.
     

     >> Share

     
     
146. ABDULMAJID B, Blanken AB, van Geel EH, Daams JG, et al
     Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2023 Jan 16. doi: 10.1007/s10067-023-06505.
     

     >> Share

     
     
147. FOGUEM C, Seror R, Gosset M
     Chemosensory dysfunction in primary Sjogren's syndrome: a topical review.
     Clin Rheumatol. 2023;42:1-14.
     

     >> Share

     
     
148. ZHU D, Meng J, Jia J, Wang M, et al
     Performance of the modified Systemic Manifestation Score for systemic juvenile idiopathic arthritis in Adult-onset Still's disease.
     Clin Rheumatol. 2023;42:187-195.
     

     >> Share

     
     
149. DOUMEN M, Bertrand D, Pazmino S, De Cock D, et al
     Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial.
     Clin Rheumatol. 2023;42:39-45.
     

     >> Share

     
     December 2022
150. INGRASCIOTTA Y, Jin Y, Foti SS, Landon JE, et al
     Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study.
     Clin Rheumatol. 2022 Dec 19. doi: 10.1007/s10067-022-06478.
     

     >> Share

     
     
151. BEN TEKAYA A, Mehmli T, Ben Sassi M, Teyeb Z, et al
     Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 Dec 3. doi: 10.1007/s10067-022-06454.
     

     >> Share

     
     
152. ARJMAND M, Shahriarirad R, Shenavandeh S, Fallahi MJ, et al
     Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran.
     Clin Rheumatol. 2022;41:3859-3868.
     

     >> Share

     
     
153. FANG S, Huang S, Tian F, Han Y, et al
     Assessment of bidirectional relationships between depression and rheumatoid arthritis among adults: a two-sample Mendelian randomization study.
     Clin Rheumatol. 2022 Dec 1. doi: 10.1007/s10067-022-06455.
     

     >> Share

     
     November 2022
154. CANSU DU, Korkmaz C
     Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
     Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
     

     >> Share

     
     
155. ZHANG S, Li P, Wu P, Yang L, et al
     Predictors of response of rituximab in rheumatoid arthritis by weighted gene co-expression network analysis.
     Clin Rheumatol. 2022 Nov 14. pii: 10.1007/s10067-022-06438.
     

     >> Share

     
     
156. OGATA-MEDEL M, Llorente L, Hinojosa-Azaola A, Lozada-Mellado M, et al
     Cachexia measured by bioelectrical impedance vector analysis and risk of infection in women with rheumatoid arthritis.
     Clin Rheumatol. 2022 Nov 14. pii: 10.1007/s10067-022-06431.
     

     >> Share

     
     
157. YOSHII I, Sawada N, Chijiwa T
     Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Nov 12. pii: 10.1007/s10067-022-06432.
     

     >> Share

     
     
158. HUANG W, Wu T, Jin T, Zhang Y, et al
     Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 Nov 11. pii: 10.1007/s10067-022-06436.
     

     >> Share

     
     
159. ZHANG X, Zhang X, Yang Y, Zhi K, et al
     Association between passive smoking and the risk of rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 Nov 11. pii: 10.1007/s10067-022-06433.
     

     >> Share

     
     
160. BHOWMICK K, Roongta R, Haldar S, Mondal S, et al
     Bilateral scleromalacia in rheumatoid arthritis.
     Clin Rheumatol. 2022 Nov 6. pii: 10.1007/s10067-022-06428.
     

     >> Share

     
     
161. WANZENRIED A, Garaiman A, Jordan S, Distler O, et al
     The enigma of mixed connective tissue disease-challenges in routine care.
     Clin Rheumatol. 2022;41:3503-3511.
     

     >> Share

     
     
162. LEE AYS, Lin MW, Reed JH
     Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
     Clin Rheumatol. 2022;41:3495-3501.
     

     >> Share

     
     
163. LI M, Liang J, Pan W, Liu L, et al
     Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort.
     Clin Rheumatol. 2022;41:3355-3362.
     

     >> Share

     
     October 2022
164. FAN DD, Tan PY, Jin L, Qu Y, et al
     Bioinformatic identification and validation of autophagy-related genes in rheumatoid arthritis.
     Clin Rheumatol. 2022 Oct 11. pii: 10.1007/s10067-022-06399.
     

     >> Share

     
     
165. COLUNGA-PEDRAZA IJ, Galarza-Delgado DA, Guajardo-Jauregui N, Cardenas-de la Garza JA, et al
     Association of soluble cell adhesion molecules and lipid levels in rheumatoid arthritis patients.
     Clin Rheumatol. 2022 Oct 3. pii: 10.1007/s10067-022-06395.
     

     >> Share

     
     
166. HARTERT M, Melcher B, Huertgen M
     Association of early-onset myasthenia gravis and primary Sjogren's syndrome: a case-based narrative review.
     Clin Rheumatol. 2022;41:3237-3243.
     

     >> Share

     
     
167. KIM JW, Jin R, Han JH, Kang JH, et al
     Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2022;41:3083-3093.
     

     >> Share

     
     
168. LI S, Yang Y, Ma R, Chen X, et al
     Primary Sjogren's syndrome is not associated with poor outcomes after total hip arthroplasty: a retrospective case-control study with a matched cohort of osteoarthritis patients.
     Clin Rheumatol. 2022;41:3075-3082.
     

     >> Share

     
     
169. MCCOY SS, Hetzel S, VanWormer JJ, Bartels CM, et al
     Sex hormones, body mass index, and related comorbidities associated with developing Sjogren's disease: a nested case-control study.
     Clin Rheumatol. 2022;41:3065-3074.
     

     >> Share

     
     
170. PERDAN-PIRKMAJER K, Fortuna K, Tersek Z, Kramaric J, et al
     Diagnostic performance of Sjogren's Syndrome Screening Questionnaire (SSSQ).
     Clin Rheumatol. 2022;41:3259-3260.
     

     >> Share

     
     September 2022
171. WANG T, Zeng F, Li X, Wei Y, et al
     Identification of key genes and pathways associated with sex differences in rheumatoid arthritis based on bioinformatics analysis.
     Clin Rheumatol. 2022 Sep 29. pii: 10.1007/s10067-022-06387.
     

     >> Share

     
     
172. TAMAI H, Nishina N, Kikuchi J, Izumi K, et al
     Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs.
     Clin Rheumatol. 2022 Sep 26. pii: 10.1007/s10067-022-06390.
     

     >> Share

     
     
173. KELLEY GA, Kelley KS
     Representation of adults with rheumatoid arthritis in US-based randomized controlled exercise trials: a systematic review with meta-analysis.
     Clin Rheumatol. 2022 Sep 24. pii: 10.1007/s10067-022-06360.
     

     >> Share

     
     
174. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
     Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Sep 22. pii: 10.1007/s10067-022-06375.
     

     >> Share

     
     
175. LI J, Li Y, Huang Y, Zhang H, et al
     Predictors and complications of blood transfusion in rheumatoid arthritis patients undergoing total joint arthroplasty.
     Clin Rheumatol. 2022 Sep 19. pii: 10.1007/s10067-022-06376.
     

     >> Share

     
     
176. GHASEMI A, Farazmand A, Hassanzadeh V, Poursani S, et al
     Upregulation of KAT2B and ESCO2 gene expression level in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Sep 15. pii: 10.1007/s10067-022-06351.
     

     >> Share

     
     
177. KHADIM RM, Al-Fartusie FS
     Evaluation of some trace elements and antioxidants in sera of patients with rheumatoid arthritis: a case-control study.
     Clin Rheumatol. 2022 Sep 1. pii: 10.1007/s10067-022-06324.
     

     >> Share

     
     August 2022
178. DE STEENWINKEL FDO, Dolhain RJEM, Hazes JMW, Hokken-Koelega ACS, et al
     Does prednisone use in pregnant women with rheumatoid arthritis induce insulin resistance in the offspring?
     Clin Rheumatol. 2022 Aug 30. pii: 10.1007/s10067-022-06347.
     

     >> Share

     
     
179. MUHAMMED H, Misra DP, Jain N, Ganguly S, et al
     The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
     Clin Rheumatol. 2022 Aug 25. pii: 10.1007/s10067-022-06349.
     

     >> Share

     
     
180. SOBEJANA M, van den Hoek J, Metsios GS, Kitas GD, et al
     Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study.
     Clin Rheumatol. 2022 Aug 25. pii: 10.1007/s10067-022-06343.
     

     >> Share

     
     
181. KHADER Y, Beran A, Ghazaleh S, Lee-Smith W, et al
     Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 Aug 16. pii: 10.1007/s10067-022-06307.
     

     >> Share

     
     
182. GUERRA JD, De Santiago AB, Reed S, Hammonds KP, et al
     Cardiology co-management of rheumatoid arthritis patients with coronary artery disease as an intervention reduces hospitalization rates and adverse event occurrence.
     Clin Rheumatol. 2022 Aug 16. pii: 10.1007/s10067-022-06335.
     

     >> Share

     
     
183. SCHAFER A, Kovacs MS, Eder A, Nigg A, et al
     Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Aug 15. pii: 10.1007/s10067-022-06329.
     

     >> Share

     
     
184. PU LM, Liu Y, Zhou DX, Tang XJ, et al
     Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Aug 10. pii: 10.1007/s10067-022-06259.
     

     >> Share

     
     
185. HOUGE IS, Hoff M, Halsan O, Videm V, et al
     Exercise Self-Efficacy and patient global assessment were associated with 6-min walk test distance in persons with rheumatoid arthritis.
     Clin Rheumatol. 2022 Aug 5. pii: 10.1007/s10067-022-06309.
     

     >> Share

     
     
186. WANG T, Rui J, Shan W, Xue F, et al
     Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Aug 4. pii: 10.1007/s10067-022-06315.
     

     >> Share

     
     
187. MISRA DP, Agarwal V
     Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases.
     Clin Rheumatol. 2022;41:2297-2308.
     

     >> Share

     
     
188. LI F, Ai W, Ye J, Wang C, et al
     Inflammatory markers and risk factors of RA patients with depression and application of different scales in judging depression.
     Clin Rheumatol. 2022;41:2309-2317.
     

     >> Share

     
     
189. WIEGEL J, Seppen BF, Ter Wee MM, Nurmohamed MT, et al
     The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study.
     Clin Rheumatol. 2022;41:2525-2531.
     

     >> Share

     
     
190. LU V, Zhou A, Hussain HA, Thahir A, et al
     Risk factors for septic arthritis and multiple arthroscopic washouts: minimum 2-year follow-up at a major trauma centre.
     Clin Rheumatol. 2022;41:2513-2523.
     

     >> Share

     
     July 2022
191. LIU S, Li J, Li Y, Liu Y, et al
     Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population.
     Clin Rheumatol. 2022 Jul 28. pii: 10.1007/s10067-022-06306.
     

     >> Share

     
     
192. SEABRA RATO M, Bernardo A, Oliveira Pinheiro F, Guimaraes da Fonseca D, et al
     The skin as the first sign of a rare complication of rheumatoid arthritis.
     Clin Rheumatol. 2022 Jul 23. pii: 10.1007/s10067-022-06303.
     

     >> Share

     
     
193. JADIDI N, Alesaeidi S, Arab F, Pakzad B, et al
     miRNA-binding site polymorphism in IL-15RA gene in rheumatoid arthritis and systemic lupus erythematosus: correlation with disease risk and clinical characteristics.
     Clin Rheumatol. 2022 Jul 20. pii: 10.1007/s10067-022-06298.
     

     >> Share

     
     
194. DENG X, Sun X, Xie W, Wang Y, et al
     The correlation of ultrasound-detected synovitis in an individual small joint with overall clinical disease activity in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Jul 18. pii: 10.1007/s10067-022-06277.
     

     >> Share

     
     
195. QUINTANA R, Fernandez S, Guggia L, Fay M, et al
     Social networks as education strategies for indigenous patients with rheumatoid arthritis during COVID-19 pandemic. Are they useful?
     Clin Rheumatol. 2022 Jul 13. pii: 10.1007/s10067-022-06273.
     

     >> Share

     
     
196. LIN W, Xin Z, Wang J, Ren X, et al
     Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome.
     Clin Rheumatol. 2022;41:2091-2102.
     

     >> Share

     
     
197. PASOTO SG, Halpern ASR, Guedes LKN, Ribeiro ACM, et al
     Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity.
     Clin Rheumatol. 2022;41:2079-2089.
     

     >> Share

     
     
198. AMEN TB, Chavez TJ, Dee EC, Varady NH, et al
     Disparities in psychological distress and access to mental health services among immigrants with rheumatologic disease.
     Clin Rheumatol. 2022;41:2205-2211.
     

     >> Share

     
     
199. MCCOY SS, Woodham M, Bunya VY, Saldanha IJ, et al
     A comprehensive overview of living with Sjogren's: results of a National Sjogren's Foundation survey.
     Clin Rheumatol. 2022;41:2071-2078.
     

     >> Share

     
     
200. PADEM N, Wright H, Fuleihan R, Garabedian E, et al
     Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.
     Clin Rheumatol. 2022;41:2197-2203.
     

     >> Share

     
     June 2022
201. PHUKAN P, Barman B, Chengappa NK, Lynser D, et al
     Diffusion tensor imaging analysis of rheumatoid arthritis patients with neuropsychiatric features to determine the alteration of white matter integrity due to vascular events.
     Clin Rheumatol. 2022 Jun 25. pii: 10.1007/s10067-022-06262.
     

     >> Share

     
     
202. MEHTA P, Redhead G, Nair A, Sparks JA, et al
     Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?
     Clin Rheumatol. 2022 Jun 22. pii: 10.1007/s10067-022-06245.
     

     >> Share

     
     
203. BOZZALLA CASSIONE E, Mansoubi M, Mazzucchelli I, Luvaro T, et al
     No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission.
     Clin Rheumatol. 2022 Jun 22. pii: 10.1007/s10067-022-06250.
     

     >> Share

     
     
204. SARHAN SA, Kamal DE, Hamed MS, Mostafa DI, et al
     Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients.
     Clin Rheumatol. 2022 Jun 15. pii: 10.1007/s10067-022-06183.
     

     >> Share

     
     
205. LUO L, Li X, Yan R, Zhang H, et al
     Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring.
     Clin Rheumatol. 2022 Jun 13. pii: 10.1007/s10067-022-06233.
     

     >> Share

     
     
206. WANG F, Tang J, Li Z, Qi Y, et al
     Oral methotrexate at doses 15-25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06221.
     

     >> Share

     
     
207. WALKER D, Goff I, Robinson S
     Real-world single-centre experience of rheumatoid arthritis patients requiring four or more higher cost drugs: response and duration of treatment.
     Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06232.
     

     >> Share

     
     
208. QIU J, Lu C, Zhang L, Zhou X, et al
     Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors.
     Clin Rheumatol. 2022 Jun 7. pii: 10.1007/s10067-022-06212.
     

     >> Share

     
     
209. ZHAI X, Wang Y, Guo H, Liang Z, et al
     Altered levels of circulating CD8(+)CXCR5(+)PD-1(+)T follicular cytotoxic cells in primary Sjogren's syndrome.
     Clin Rheumatol. 2022;41:1697-1708.
     

     >> Share

     
     
210. YANG Y, Yuan X, Wang X, Tao R, et al
     Preliminary MRI-based investigation of characteristics and prognosis of knee bone marrow edema in children with juvenile idiopathic arthritis.
     Clin Rheumatol. 2022;41:1793-1799.
     

     >> Share

     
     
211. GIESEN T, Sanduleanu S, Jansen TLTA
     Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study.
     Clin Rheumatol. 2022;41:1833-1841.
     

     >> Share

     
     May 2022
212. XIANG S, Wang Y, Qian S, Li J, et al
     The association between dietary inflammation index and the risk of rheumatoid arthritis in Americans.
     Clin Rheumatol. 2022 May 28. pii: 10.1007/s10067-022-06217.
     

     >> Share

     
     
213. ZHANG YF, Gao SS, Li JL, Zuo WS, et al
     Comparison and correlation study of synovial ultrasound indices and serum VEGF in rheumatoid wrist arthritis before and after treatment.
     Clin Rheumatol. 2022 May 27. pii: 10.1007/s10067-022-06213.
     

     >> Share

     
     
214. ZHU T, Pan Z, Zhang N
     Elevated CXCL13 in primary Sjogren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
     Clin Rheumatol. 2022 May 26. pii: 10.1007/s10067-022-06210.
     

     >> Share

     
     
215. EZEANUNA MN, Prince DK, Alexander SA, Richards JS, et al
     Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study.
     Clin Rheumatol. 2022 May 25. pii: 10.1007/s10067-022-06223.
     

     >> Share

     
     
216. PHATAK S, Khenat A, Malandkar M, Amin S, et al
     Real-world evidence of the effectiveness and safety of generic tofacitinib in rheumatoid arthritis patients: a retrospective, single-centre analysis from Western India.
     Clin Rheumatol. 2022 May 21. pii: 10.1007/s10067-022-06205.
     

     >> Share

     
     
217. WANG R, Li T, Ye S, Lv L, et al
     Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
     Clin Rheumatol. 2022 May 19. pii: 10.1007/s10067-022-06184.
     

     >> Share

     
     
218. ZHAO JL, Liu X, Nan Li J, Ru Liu M, et al
     Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists.
     Clin Rheumatol. 2022 May 17. pii: 10.1007/s10067-022-06187.
     

     >> Share

     
     
219. LIU Y, Zheng B, Hong J, Liu Y, et al
     Mapping theme trends and knowledge structure of Sjogren's syndrome (SS), a bibliometric analysis from 2010 to 2021.
     Clin Rheumatol. 2022 May 14. pii: 10.1007/s10067-022-06196.
     

     >> Share

     
     
220. DU Y, Li J, Wu J, Zeng F, et al
     Exploration of the pathogenesis of Sjogren's syndrome via DNA methylation and transcriptome analyses.
     Clin Rheumatol. 2022 May 13. pii: 10.1007/s10067-022-06200.
     

     >> Share

     
     
221. ALTEN R, Mariette X, Flipo RM, Caporali R, et al
     Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study.
     Clin Rheumatol. 2022 May 10. pii: 10.1007/s10067-022-06176.
     

     >> Share

     
     
222. POGGENBORG RP, Madsen OR, Sweeney AT, Dreyer L, et al
     Correction to: Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trial.
     Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06193.
     

     >> Share

     
     
223. CHU Y, Xu S
     Rebuttal letter referring to the article "Synergy of sarcopaenia and vitamin D deficiency in vertebral osteoporotic fractures in rheumatoid arthritis".
     Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06188.
     

     >> Share

     
     
224. KARA M, Ozcakar L
     Synergy or a third (causative) factor for fractures in rheumatoid arthritis?
     Clin Rheumatol. 2022 May 5. pii: 10.1007/s10067-022-06173.
     

     >> Share

     
     
225. ROONGTA R, Mondal S, Haldar S, Kumar MS, et al
     Two flares of Still's disease after two doses of the ChAdOx1 vaccine.
     Clin Rheumatol. 2022;41:1591-1596.
     

     >> Share

     
     
226. KIM JW, Jung JY, Suh CH, Kim HA, et al
     Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature.
     Clin Rheumatol. 2022;41:1583-1589.
     

     >> Share

     
     
227. SAHOO RR, Wakhlu A, Agarwal V
     Neglected tropical rheumatic diseases.
     Clin Rheumatol. 2022;41:1293-1304.
     

     >> Share

     
     
228. LV X, Zhou M, Zhang Q, He Y, et al
     Abnormal Histones Acetylation in Patients with Primary Sjogren's Syndrome.
     Clin Rheumatol. 2022;41:1465-1472.
     

     >> Share

     
     
229. VEGA-MORALES D, Del Carmen Larios-Forte M, Perez-Barbosa L, Esquivel-Valerio JA, et al
     Bone erosions by MRI in first-degree relatives of patients with RA: an exploratory study.
     Clin Rheumatol. 2022;41:1343-1348.
     

     >> Share

     
     
230. KATZ G, Ogdie A, Baker JF, George MD, et al
     Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis.
     Clin Rheumatol. 2022;41:1323-1331.
     

     >> Share

     
     
231. PADIYAR S, Kamath N, Mathew J, Chandu AS, et al
     New-onset Adult-onset Still's disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature.
     Clin Rheumatol. 2022;41:1569-1575.
     

     >> Share

     
     
232. YAYLA ME, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer AB, et al
     Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey.
     Clin Rheumatol. 2022;41:1457-1463.
     

     >> Share

     
     April 2022
233. ANDERS B, Anders M, Kreuzer M, Zinn S, et al
     Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Apr 30. pii: 10.1007/s10067-022-06185.
     

     >> Share

     
     
234. DOGAN S, Kimyon G, Ozkan H, Kacmaz F, et al
     TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy.
     Clin Rheumatol. 2022 Apr 25. pii: 10.1007/s10067-022-06180.
     

     >> Share

     
     
235. GENG L, Qu W, Wang S, Chen J, et al
     Prediction of diagnosis results of rheumatoid arthritis patients based on autoantibodies and cost-sensitive neural network.
     Clin Rheumatol. 2022 Apr 11. pii: 10.1007/s10067-022-06109.
     

     >> Share

     
     
236. CHEN C, Liang Y, Yang Z
     Can Raynaud's phenomenon be defined as a subtype of primary Sjogren's syndrome? Comments on "Clinical features and risk factors of Raynaud's phenomenon in primary Sjogren's syndrome".
     Clin Rheumatol. 2022;41:1265-1266.
     

     >> Share

     
     
237. ZHOU X, Li Q, Li Y, Fu J, et al
     Diminished natural killer T-like cells correlates with aggravated primary Sjogren's syndrome.
     Clin Rheumatol. 2022;41:1163-1168.
     

     >> Share

     
     
238. SUMETHKUL K, Urailert I, Kitumnuaypong T, Angthararak S, et al
     The incidence, risk factor, and time to develop rheumatologic diseases after isolated inflammatory eye diseases: a 12-year cohort study.
     Clin Rheumatol. 2022;41:1003-1012.
     

     >> Share

     
     
239. HE SH, He YJ, Guo KJ, Liang X, et al
     Risk factors for progression of interstitial lung disease in Sjogren's syndrome: a single-centered, retrospective study.
     Clin Rheumatol. 2022;41:1153-1161.
     

     >> Share

     
     
240. DARDIN LP, Garcia ABA, Minali PA, Pinto ACPN, et al
     The effects of resistance training in patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2022;41:1145-1152.
     

     >> Share

     
     
241. JAIN V, Kumar S
     Intermetatarsal bursitis in the foot as the initial manifestation of rheumatoid arthritis.
     Clin Rheumatol. 2022 Apr 1. pii: 10.1007/s10067-022-06123.
     

     >> Share

     
     
242. WEI L, Liu Y, Fengxiao Z
     Comment on: Can Raynaud's phenomenon be defined as a subtype of primary Sjogren's syndrome? Comments on "Clinical features and risk factors of Raynaud's phenomenon in primary Sjogren's syndrome" Reply.
     Clin Rheumatol. 2022;41:1267-1268.
     

     >> Share

     
     March 2022
243. TADA M, Yamada Y, Mandai K, Matsumoto Y, et al
     Daily physical activity measured by a wearable activity monitoring device in patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Mar 31. pii: 10.1007/s10067-022-06147.
     

     >> Share

     
     
244. YILDIRIM A, Onder ME, Ozkan D
     Correction to: Ultrasonographic evaluation of distal femoral and talar cartilage thicknesses in patients with early rheumatoid arthritis and their relationship with disease activity.
     Clin Rheumatol. 2022 Mar 30. pii: 10.1007/s10067-022-06152.
     

     >> Share

     
     
245. ZEINALZADEH S, Kheradmand N, Rasouli G, Esmaeilzadeh E, et al
     Association of a miRNA-binding site polymorphism in IL-16 gene with disease risk and clinical characteristics of rheumatoid arthritis and systemic lupus erythematosus.
     Clin Rheumatol. 2022 Mar 24. pii: 10.1007/s10067-022-06131.
     

     >> Share

     
     
246. TESSER J, Lin I, Shiff NJ, Chakravarty SD, et al
     Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.
     Clin Rheumatol. 2022 Mar 21. pii: 10.1007/s10067-022-06116.
     

     >> Share

     
     
247. YILDIRIM A, Onder ME, Ozkan D
     Ultrasonographic evaluation of distal femoral and talar cartilage thicknesses in patients with early rheumatoid arthritis and their relationship with disease activity.
     Clin Rheumatol. 2022 Mar 19. pii: 10.1007/s10067-022-06132.
     

     >> Share

     
     
248. XU Y, He H, Zang Y, Yu Z, et al
     Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study.
     Clin Rheumatol. 2022 Mar 9. pii: 10.1007/s10067-022-06122.
     

     >> Share

     
     
249. CHU YR, Xu SQ, Wang JX, Zong HX, et al
     Synergy of sarcopenia and vitamin D deficiency in vertebral osteoporotic fractures in rheumatoid arthritis.
     Clin Rheumatol. 2022 Mar 6. pii: 10.1007/s10067-022-06125.
     

     >> Share

     
     
250. KAWADA T
     Risk factors for progression of interstitial lung disease in Sjogren's syndrome.
     Clin Rheumatol. 2022;41:955.
     

     >> Share

     
     
251. CHEN Z, Li Y, Wang Q, Weng S, et al
     Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patients.
     Clin Rheumatol. 2022;41:839-846.
     

     >> Share

     
     
252. RUSCITTI P, Di Cola I, Berardicurti O, Conforti A, et al
     Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
     Clin Rheumatol. 2022;41:641-647.
     

     >> Share

     
     
253. JAIME-PEREZ JC, Gonzalez-Trevino M, Melendez-Flores JD, Ramos-Davila EM, et al
     Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort.
     Clin Rheumatol. 2022;41:869-876.
     

     >> Share

     
     February 2022
254. CHOI W, Ahn SM, Kim YG, Lee CK, et al
     Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors.
     Clin Rheumatol. 2022 Feb 14. pii: 10.1007/s10067-022-06096.
     

     >> Share

     
     
255. ROJAS-SERRANO J, Mejia M, Rivera-Matias PA, Herrera-Bringas D, et al
     Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis.
     Clin Rheumatol. 2022 Feb 3. pii: 10.1007/s10067-021-06040.
     

     >> Share

     
     
256. SGHIRI R, Benhassine H, Baccouche K, Ghozzi M, et al
     A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis.
     Clin Rheumatol. 2022 Feb 2. pii: 10.1007/s10067-021-05998.
     

     >> Share

     
     
257. TANG KT, Hsieh CW, Chen HH, Chen YM, et al
     The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.
     Clin Rheumatol. 2022;41:557-566.
     

     >> Share

     
     
258. XIN L, Zhu Y, Liu J, Fang Y, et al
     Exposure-lag-response associations between extreme environmental conditions and primary Sjogren's syndrome.
     Clin Rheumatol. 2022;41:523-532.
     

     >> Share

     
     
259. SAHA BK, Chong WH, Milman NT
     Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.
     Clin Rheumatol. 2022;41:325-336.
     

     >> Share

     
     
260. ZACARIAZ HERETER J, Rosa JE, Mollerach FB, Marin J, et al
     Ultrasound-detected tenosynovitis as a risk factor for flares in rheumatoid arthritis patients in clinical remission.
     Clin Rheumatol. 2022 Feb 1. pii: 10.1007/s10067-022-06079.
     

     >> Share

     
     January 2022
261. SUN C, Qi X, Yang Y, Lei L, et al
     Correction to: Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis.
     Clin Rheumatol. 2022 Jan 28. pii: 10.1007/s10067-022-06083.
     

     >> Share

     
     
262. LI N, Gou ZP, Du SQ, Zhu XH, et al
     Correction to: Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis.
     Clin Rheumatol. 2022 Jan 27. pii: 10.1007/s10067-022-06064.
     

     >> Share

     
     
263. GAO C, Zhong H, Chen L, Wang L, et al
     Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study.
     Clin Rheumatol. 2022 Jan 24. pii: 10.1007/s10067-021-06026.
     

     >> Share

     
     
264. SENOSI MR, Fathi HM, Baki NMA, Zaki O, et al
     Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle.
     Clin Rheumatol. 2022 Jan 19. pii: 10.1007/s10067-022-06048.
     

     >> Share

     
     
265. SUN C, Qi X, Yang Y, Lei L, et al
     Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis.
     Clin Rheumatol. 2022 Jan 18. pii: 10.1007/s10067-021-06017.
     

     >> Share

     
     
266. BIXIO R, Bertelle D, Pistillo F, Pedrollo E, et al
     Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.
     Clin Rheumatol. 2022 Jan 14. pii: 10.1007/s10067-022-06062.
     

     >> Share

     
     
267. LIU Y, Jiang J, Mo M, Sun X, et al
     Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.
     Clin Rheumatol. 2022 Jan 10. pii: 10.1007/s10067-021-06046.
     

     >> Share

     
     
268. ZHU G, Zhou S, Xu Y, Gao R, et al
     Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis.
     Clin Rheumatol. 2022 Jan 8. pii: 10.1007/s10067-022-06052.
     

     >> Share

     
     
269. LI N, Gou ZP, Du SQ, Zhu XH, et al
     Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis.
     Clin Rheumatol. 2022 Jan 7. pii: 10.1007/s10067-021-06003.
     

     >> Share

     
     
270. MUELLER RB, Schulze-Koops H, Furst DE, Cohen SB, et al
     Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
     Clin Rheumatol. 2022 Jan 1. pii: 10.1007/s10067-021-05908.
     

     >> Share

     
     
271. WANG Y, Liu R, Zhao P, Zhang Q, et al
     Blockade of adiponectin receptor 1 signaling inhibits synovial inflammation and alleviates joint damage in collagen-induced arthritis.
     Clin Rheumatol. 2022;41:255-264.
     

     >> Share

     
     December 2021
272. LEBLEBICI G, Ovacik U, Gungor F, Davids JR, et al
     Validity and reliability of "Shriners Hospital for Children Upper Extremity Evaluation" in children with rheumatic diseases.
     Clin Rheumatol. 2021;40:5033-5040.
     

     >> Share

     
     
273. VIEGAS-COSTA LC, Friesen R, Flores-Mir C, McGaw T, et al
     Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.
     Clin Rheumatol. 2021;40:4817-4828.
     

     >> Share

     
     
274. RAI B, Pillinger MH, Panush RS
     Coincident Kikuchi-Fujimoto's disease and adult-onset Still's disease: report of a patient from an uncommonly affected population and case-directed systematic review.
     Clin Rheumatol. 2021;40:4791-4805.
     

     >> Share

     
     November 2021
275. HEIJKE R, Bjork M, Thyberg I, Kastbom A, et al
     Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
     Clin Rheumatol. 2021 Nov 27. pii: 10.1007/s10067-021-05982.
     

     >> Share

     
     
276. ARONSSON M, Bergman S, Lindqvist E, Andersson MLE, et al
     Comparison of chronic widespread pain prevalence with different criteria in two cohorts of rheumatoid arthritis.
     Clin Rheumatol. 2021 Nov 23. pii: 10.1007/s10067-021-05999.
     

     >> Share

     
     
277. NAGAFUCHI H, Goto Y, Kiyokawa T, Ooka S, et al
     Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive.
     Clin Rheumatol. 2021 Nov 15. pii: 10.1007/s10067-021-05985.
     

     >> Share

     
     
278. CHEN Y, Liao R, Yao Y, Wang Q, et al
     Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network.
     Clin Rheumatol. 2021 Nov 12. pii: 10.1007/s10067-021-05960.
     

     >> Share

     
     
279. MIRTAHERI E, Khabbazi A, Nazemiyeh H, Ebrahimi AA, et al
     Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial.
     Clin Rheumatol. 2021 Nov 11. pii: 10.1007/s10067-021-05981.
     

     >> Share

     
     
280. LORENZIN M, Ortolan A, Cozzi G, Calligaro A, et al
     Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFalpha, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study.
     Clin Rheumatol. 2021;40:4569-4580.
     

     >> Share

     
     
281. UCHIO A, Matsumoto T, Maenohara Y, Omata Y, et al
     Correction to: Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib.
     Clin Rheumatol. 2021 Nov 1. pii: 10.1007/s10067-021-05976.
     

     >> Share

     
     October 2021
282. GENG Y, Gao T, Zhang X, Wang Y, et al
     The association between disease duration and mood disorders in rheumatoid arthritis patients.
     Clin Rheumatol. 2021 Oct 24. pii: 10.1007/s10067-021-05967.
     

     >> Share

     
     
283. DOS REIS BS, Staub FC, Koishi A, Zanluca C, et al
     Seroconversion of rheumatoid arthritis patients after yellow fever vaccination.
     Clin Rheumatol. 2021 Oct 21. pii: 10.1007/s10067-021-05962.
     

     >> Share

     
     
284. BYWALL KS, Esbensen BA, Lason M, Heidenvall M, et al
     Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis.
     Clin Rheumatol. 2021 Oct 15. pii: 10.1007/s10067-021-05961.
     

     >> Share

     
     
285. HEE JY, Protani MM, Koh ET, Leong KP, et al
     Metabolic syndrome and its effect on the outcomes of rheumatoid arthritis in a multi-ethnic cohort in Singapore.
     Clin Rheumatol. 2021 Oct 15. pii: 10.1007/s10067-021-05945.
     

     >> Share

     
     
286. ZHANG C, Lyu A
     Novel research synergized by Chinese medicine pattern classification in rheumatoid arthritis.
     Clin Rheumatol. 2021 Oct 9. pii: 10.1007/s10067-021-05955.
     

     >> Share

     
     
287. SUH CH, Lee K, Kim JW, Boo S, et al
     Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study.
     Clin Rheumatol. 2021 Oct 5. pii: 10.1007/s10067-021-05944.
     

     >> Share

     
     
288. YIN R, Wang G, Yang X, Zhang L, et al
     Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.
     Clin Rheumatol. 2021;40:3951-3960.
     

     >> Share

     
     
289. SAWKA E, Zhou A, Latour E, Friedman M, et al
     Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
     Clin Rheumatol. 2021;40:3963-3969.
     

     >> Share

     
     
290. MALEK MAHDAVI A, Khalili A, Alihosseini S, Jaberinezhad M, et al
     Efficacy of tight control strategy in the treatment of adult-onset Still disease.
     Clin Rheumatol. 2021;40:3941-3949.
     

     >> Share

     
     
291. LIN W, Xin Z, Ning X, Li Y, et al
     Clinical features and risk factors of Raynaud's phenomenon in primary Sjogren's syndrome.
     Clin Rheumatol. 2021;40:4081-4087.
     

     >> Share

     
     
292. CHUNG SH, Bent EI, Weiss MD, Gardner GC, et al
     Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
     Clin Rheumatol. 2021;40:4089-4094.
     

     >> Share

     
     
293. DI COLA I, Bruno F, Berardicurti O, Monti R, et al
     Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
     Clin Rheumatol. 2021;40:3971-3978.
     

     >> Share

     
     September 2021
294. FURUYA T, Oh K, Ikari K, Inoue E, et al
     Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.
     Clin Rheumatol. 2021 Sep 29. pii: 10.1007/s10067-021-05938.
     

     >> Share

     
     
295. ITAYA T, Torii M, Hashimoto M, Jindai K, et al
     Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional study.
     Clin Rheumatol. 2021 Sep 28. pii: 10.1007/s10067-021-05840.
     

     >> Share

     
     
296. FLEISCHMANN R
     Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis.
     Clin Rheumatol. 2021 Sep 24. pii: 10.1007/s10067-021-05933.
     

     >> Share

     
     
297. MORI S, Ogata F, Tsunoda R
     Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.
     Clin Rheumatol. 2021 Sep 23. pii: 10.1007/s10067-021-05911.
     

     >> Share

     
     
298. AKIHIRO U, Matsumoto T, Maenohara Y, Omata Y, et al
     Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib.
     Clin Rheumatol. 2021 Sep 21. pii: 10.1007/s10067-021-05914.
     

     >> Share

     
     
299. CHALLENER GJ, Myasoedova E, Crowson CS, Giblon RE, et al
     Body mass index trend and variability in rheumatoid arthritis.
     Clin Rheumatol. 2021 Sep 11. pii: 10.1007/s10067-021-05919.
     

     >> Share

     
     
300. BEN NESSIB D, Maatallah K, Ferjani H, Triki W, et al
     Sustainable positive effects of Ramadan intermittent fasting in rheumatoid arthritis.
     Clin Rheumatol. 2021 Sep 10. pii: 10.1007/s10067-021-05892.
     

     >> Share

     
     
301. KARSTENSEN JK, Primdahl J, Andersson MLE, Christensen JR, et al
     Lifestyle factors in patients with rheumatoid arthritis-a cross-sectional study on two Scandinavian cohorts.
     Clin Rheumatol. 2021 Sep 9. pii: 10.1007/s10067-021-05905.
     

     >> Share

     
     
302. SHAO M, Xie H, Yang H, Xu W, et al
     Association of interleukin-6 promoter polymorphism with rheumatoid arthritis: a meta-analysis with trial sequential analysis.
     Clin Rheumatol. 2021 Sep 8. pii: 10.1007/s10067-021-05886.
     

     >> Share

     
     
303. POURNAZARI M, Feizollahi P, Roghani SA, Assar S, et al
     Increased plasma levels of CCL20 in peripheral blood of rheumatoid arthritis patients and its association with clinical and laboratory parameters.
     Clin Rheumatol. 2021 Sep 3. pii: 10.1007/s10067-021-05899.
     

     >> Share

     
     
304. HE S, Zhen X, Hu Y
     Juvenile primary Sjogren's syndrome with cutaneous involvement.
     Clin Rheumatol. 2021;40:3687-3694.
     

     >> Share

     
     
305. HSU HC, Chang YS, Hou TY, Chen LF, et al
     Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
     Clin Rheumatol. 2021;40:3755-3763.
     

     >> Share

     
     August 2021
306. TAN C, Luo X, Li S, Yi L, et al
     Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis.
     Clin Rheumatol. 2021 Aug 10. pii: 10.1007/s10067-021-05876.
     

     >> Share

     
     
307. BIRD P, Littlejohn G, Butcher B, Smith T, et al
     Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.
     Clin Rheumatol. 2021 Aug 9. pii: 10.1007/s10067-021-05853.
     

     >> Share

     
     
308. LI H, Lu Y
     Pulmonary amyloidosis and cystic lung disease in primary Sjogren's syndrome: a case report and literature review.
     Clin Rheumatol. 2021;40:3345-3350.
     

     >> Share

     
     July 2021
309. TARDELLA M, Di Carlo M, Carotti M, Giovagnoni A, et al
     Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
     Clin Rheumatol. 2021 Jul 27. pii: 10.1007/s10067-021-05854.
     

     >> Share

     
     
310. KROESE JM, Kopp S, Lobbezoo F, Alstergren P, et al
     Corticosteroid injections in the temporomandibular joint temporarily alleviate pain and improve function in rheumatoid arthritis.
     Clin Rheumatol. 2021 Jul 21. pii: 10.1007/s10067-021-05860.
     

     >> Share

     
     
311. SALAFFI F, De Angelis R, Farah S, Carotti M, et al
     Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis.
     Clin Rheumatol. 2021 Jul 20. pii: 10.1007/s10067-021-05744.
     

     >> Share

     
     
312. SGHIRI R, Boumiza A, Benhassine H, Elamri N, et al
     IgA rheumatoid factor is associated with bone mineral density preservation in rheumatoid arthritis.
     Clin Rheumatol. 2021 Jul 20. pii: 10.1007/s10067-021-05814.
     

     >> Share

     
     
313. MORRIS NT, Brook J, Ben-Artzi A, Martin W, et al
     Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
     Clin Rheumatol. 2021 Jul 16. pii: 10.1007/s10067-021-05857.
     

     >> Share

     
     
314. POTERA J, Kambhatla S, Gauto-Mariotti E, Manadan A, et al
     Incidence, mortality, and national costs of hospital admissions for potentially preventable infections in patients with rheumatoid arthritis.
     Clin Rheumatol. 2021 Jul 12. pii: 10.1007/s10067-021-05836.
     

     >> Share

     
     
315. MACARRON PEREZ P, Morales Lozano MDR, Vadillo Font C, Abasolo Alcazar L, et al
     Multidisciplinary approach in the treatment of tendinous foot involvement in rheumatoid arthritis.
     Clin Rheumatol. 2021 Jul 6. pii: 10.1007/s10067-021-05848.
     

     >> Share

     
     
316. ZHANG R, Zhou X, Jin Y, Chang C, et al
     Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysis.
     Clin Rheumatol. 2021 Jul 5. pii: 10.1007/s10067-021-05825.
     

     >> Share

     
     
317. ELSAMAN AM, Maaty A, Hamed A
     Genicular nerve block in rheumatoid arthritis: a randomized clinical trial.
     Clin Rheumatol. 2021 Jul 2. pii: 10.1007/s10067-021-05821.
     

     >> Share

     
     
318. BARCELOS F, Martins C, Madeira N, Angelo-Dias M, et al
     Lymphocyte subpopulations in Sjogren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
     Clin Rheumatol. 2021;40:2791-2804.
     

     >> Share

     
     
319. RINGER A, Ruffino JP, Leiva R, Cuadranti N, et al
     Chagas disease reactivation in rheumatologic patients: association with immunosuppressive therapy and humoral response.
     Clin Rheumatol. 2021;40:2955-2963.
     

     >> Share

     
     
320. NAJAFIZADEH SR, Amiri K, Moghaddassi M, Khanmohammadi S, et al
     Correction to: Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
     Clin Rheumatol. 2021 Jul 1. pii: 10.1007/s10067-021-05823.
     

     >> Share

     
     June 2021
321. MALEK MAHDAVI A, Varshochi M, Hajialilo M, Dastgiri S, et al
     Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis.
     Clin Rheumatol. 2021 Jun 29. pii: 10.1007/s10067-021-05830.
     

     >> Share

     
     
322. XIE S, Li S, Chen B, Zhu Q, et al
     Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
     Clin Rheumatol. 2021 Jun 29. pii: 10.1007/s10067-021-05808.
     

     >> Share

     
     
323. TANSKI W, Gac P, Chachaj A, Sobieszczanska M, et al
     Selected clinical parameters and changes in cardiac morphology and function assessed by magnetic resonance imaging in patients with rheumatoid arthritis and ankylosing spondylitis without clinically apparent heart disease.
     Clin Rheumatol. 2021 Jun 26. pii: 10.1007/s10067-021-05777.
     

     >> Share

     
     
324. EBRAHIMIAN S, Salami A, Malek Mahdavi A, Esalatmanesh K, et al
     Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study.
     Clin Rheumatol. 2021 Jun 23. pii: 10.1007/s10067-021-05831.
     

     >> Share

     
     
325. SALARI N, Kazeminia M, Shohaimi S, Mohammadi M, et al
     Socioeconomic inequality in patients with rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2021 Jun 22. pii: 10.1007/s10067-021-05829.
     

     >> Share

     
     
326. YUAN W, Lei Y, Tang C, Qin F, et al
     Quantification of bone marrow edema in rheumatoid arthritis by using high-speed T2-corrected multiecho acquisition of (1)H magnetic resonance spectroscopy: a feasibility study.
     Clin Rheumatol. 2021 Jun 21. pii: 10.1007/s10067-021-05764.
     

     >> Share

     
     
327. ASAI S, Takahashi N, Kobayakawa T, Kaneko A, et al
     Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
     Clin Rheumatol. 2021 Jun 16. pii: 10.1007/s10067-021-05815.
     

     >> Share

     
     
328. CHOI SR, Park JW, Lee EB, Park JK, et al
     Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
     Clin Rheumatol. 2021 Jun 11. pii: 10.1007/s10067-021-05811.
     

     >> Share

     
     
329. VIVAS AJ, Bautista-Vargas M, Portacio S, Garces-Palacio A, et al
     Reproducibility of minor salivary gland biopsy reports in Sjogren's syndrome and its correlation with disease biomarkers.
     Clin Rheumatol. 2021;40:2285-2292.
     

     >> Share

     
     
330. BAKER JF, Curtis JR, Chernoff D, Flake DD 2nd, et al
     Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustment.
     Clin Rheumatol. 2021;40:2419-2426.
     

     >> Share

     
     
331. DE CARVALHO JF, Lerner A, Goncalves CM, Shoenfeld Y, et al
     Sjogren syndrome associated with protein-losing enteropathy: case-based review.
     Clin Rheumatol. 2021;40:2491-2497.
     

     >> Share

     
     
332. SHAO Q
     Biologic therapy in Sjogren's syndrome.
     Clin Rheumatol. 2021;40:2143-2154.
     

     >> Share

     
     
333. MULLER R, Briantais A, Faucher B, Borentain P, et al
     Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestation.
     Clin Rheumatol. 2021;40:2467-2476.
     

     >> Share

     
     May 2021
334. NAJAFIZADEH SR, Amiri K, Moghaddassi M, Khanmohammadi S, et al
     Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
     Clin Rheumatol. 2021 May 28. pii: 10.1007/s10067-021-05771.
     

     >> Share

     
     
335. ZHENG L, Hu F, Bian W, Li Y, et al
     Dickkopf-1 perpetuated synovial fibroblast activation and synovial angiogenesis in rheumatoid arthritis.
     Clin Rheumatol. 2021 May 19. pii: 10.1007/s10067-021-05766.
     

     >> Share

     
     
336. YIN Y, Liu M, Zhou E, Chang X, et al
     Efficacy and safety of jakinibs in rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2021 May 14. pii: 10.1007/s10067-021-05686.
     

     >> Share

     
     
337. JIN Z, Hao D, Song Y, Zhuang L, et al
     Systemic inflammatory response index as an independent risk factor for ischemic stroke in patients with rheumatoid arthritis: a retrospective study based on propensity score matching.
     Clin Rheumatol. 2021 May 9. pii: 10.1007/s10067-021-05762.
     

     >> Share

     
     
338. LI H, Zhu H, Xu L, Xue J, et al
     The characteristics and its contributing factors of refractory rheumatoid arthritis, view of the rheumatologists of China: results of a nationwide cross-sectional survey.
     Clin Rheumatol. 2021 May 3. pii: 10.1007/s10067-021-05687.
     

     >> Share

     
     
339. ANDERSSON ML, Svensson B, Forslind K
     Distribution of erosions in hands and feet at the time for the diagnosis of RA and during 8-year follow-up.
     Clin Rheumatol. 2021;40:1799-1810.
     

     >> Share

     
     
340. DE CERQUEIRA DPA, Pedreira ALS, de Cerqueira MG, Santiago MB, et al
     Biological therapy in rheumatoid vasculitis: a systematic review.
     Clin Rheumatol. 2021;40:1717-1724.
     

     >> Share

     
     
341. CHOI Y, Lee CH, Kim IH, Park EH, et al
     Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study.
     Clin Rheumatol. 2021;40:2037-2045.
     

     >> Share

     
     
342. GARCIA-GONZALEZ M, Gonzalez-Soto MJ, Gomez Rodriguez-Bethencourt MA, Ferraz-Amaro I, et al
     The validity of salivary gland scintigraphy in Sjogren's syndrome diagnosis: comparison of visual and excretion fraction analyses.
     Clin Rheumatol. 2021;40:1923-1931.
     

     >> Share

     
     April 2021
343. SHRESTHA S, Zhao J, Yang C, Zhang J, et al
     Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2021 Apr 29. pii: 10.1007/s10067-021-05746.
     

     >> Share

     
     
344. POMBO-SUAREZ M, Sanchez-Piedra C, Garcia-Magallon B, Perez-Gomez A, et al
     Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
     Clin Rheumatol. 2021 Apr 27. pii: 10.1007/s10067-021-05742.
     

     >> Share

     
     
345. MENA-VAZQUEZ N, Jimenez-Nunez FG, Godoy-Navarrete FJ, Manrique-Arija S, et al
     Correction to: Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis.
     Clin Rheumatol. 2021 Apr 18. pii: 10.1007/s10067-021-05737.
     

     >> Share

     
     
346. FORNARO M, Righetti G, Abbruzzese A, Lopalco G, et al
     High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
     Clin Rheumatol. 2021 Apr 16. pii: 10.1007/s10067-021-05728.
     

     >> Share

     
     
347. OUEDERNI M, Sassi H, Cheour M
     Multinodular scleritis in a patient with rheumatoid arthritis.
     Clin Rheumatol. 2021 Apr 16. pii: 10.1007/s10067-021-05736.
     

     >> Share

     
     
348. PILITSI E, Kissin E
     Heel fat pad involvement in rheumatoid arthritis: a review and case series.
     Clin Rheumatol. 2021 Apr 4. pii: 10.1007/s10067-021-05725.
     

     >> Share

     
     
349. TOPCU A, Mursaloglu HH, Yalcinkaya Y, Karakurt S, et al
     Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.
     Clin Rheumatol. 2021 Apr 3. pii: 10.1007/s10067-021-05693.
     

     >> Share

     
     
350. HASSAN WA, Medhat BM, Youssef MM, Farag Y, et al
     Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.
     Clin Rheumatol. 2021;40:1599-1610.
     

     >> Share

     
     
351. SOOD A, Raji MA
     Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.
     Clin Rheumatol. 2021;40:1221-1231.
     

     >> Share

     
     
352. SHARMA A, Kasetty A, Kumar A
     Rheumatoid lung nodules with "feeding-vessel" sign.
     Clin Rheumatol. 2021;40:1645-1647.
     

     >> Share

     
     March 2021
353. WALISZEWSKA-PROSOL M, Sebastian A, Wiland P, Budrewicz S, et al
     Brainstem auditory evoked potentials in patients with primary Sjogren's syndrome without central nervous system involvement.
     Clin Rheumatol. 2021;40:991-997.
     

     >> Share

     
     
354. LAU CS, Chen YH, Lim K, de Longueville M, et al
     Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.
     Clin Rheumatol. 2021;40:867-875.
     

     >> Share

     
     
355. CARRION-BARBERA I, Zuccarino F, Escalante FA, Salman-Monte TC, et al
     Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review.
     Clin Rheumatol. 2021;40:1175-1184.
     

     >> Share

     
     
356. SKOPIS M, Elghawy AA, Pociurko B, Oh KS, et al
     Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review.
     Clin Rheumatol. 2021;40:1141-1145.
     

     >> Share

     
     February 2021
357. CHANG CC, Yen YC, Lee CY, Lin CF, et al
     Lower risk of primary Sjogren's syndrome in patients with dengue virus infection: a nationwide cohort study in Taiwan.
     Clin Rheumatol. 2021;40:537-546.
     

     >> Share

     
     
358. KIM JW, Jung JY, Suh CH, Kim HA, et al
     Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease.
     Clin Rheumatol. 2021;40:661-668.
     

     >> Share

     
     
359. DONG X, Gao YL, Lu Y, Zheng Y, et al
     Characteristics of primary Sjogren's syndrome related lymphocytic interstitial pneumonia.
     Clin Rheumatol. 2021;40:601-612.
     

     >> Share

     
     
360. LI M, Luo X, Long X, Jiang P, et al
     Potential role of mitochondria in synoviocytes.
     Clin Rheumatol. 2021;40:447-457.
     

     >> Share

     
     January 2021
361. USLU S, Inel TY, Salbas CS
     Jaccoud arthropathy in a patient with rhupus.
     Clin Rheumatol. 2021;40:423-424.
     

     >> Share

     
     
362. SANTOS M, Rodrigues D, Santos H, Parente C, et al
     Neurological manifestations of adult-onset Still's disease-case-based review.
     Clin Rheumatol. 2021;40:407-411.
     

     >> Share

     
     
363. BRUNI C, Bitti R, Nacci F, Cometi L, et al
     Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases.
     Clin Rheumatol. 2021;40:85-91.
     

     >> Share

     
     
364. YAZISIZ V, Aslan B, Erbasan F, Ucar I, et al
     Clinical and serological characteristics of seronegative primary Sjogren's syndrome: a comparative study.
     Clin Rheumatol. 2021;40:221-229.
     

     >> Share

     
     August 2020
365. BEN NESSIB D, Maatallah K, Ferjani H, Kaffel D, et al
     Impact of Ramadan diurnal intermittent fasting on rheumatic diseases.
     Clin Rheumatol. 2020;39:2433-2440.
     

     >> Share

     
     
366. WANG R, Li T, Ye S, Tan W, et al
     Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
     Clin Rheumatol. 2020;39:2379-2386.
     

     >> Share

     
     
367. ZHOU Y, Zhang X, Chen R, Han S, et al
     Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
     Clin Rheumatol. 2020;39:2325-2336.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share